Lifecore Biomedical Inc
LFCR6.850USD
+0.230+3.47%
收盤 11/07, 16:00（美東）報價延遲15分鐘
256.64M總市值
虧損本益比TTM
關於 Lifecore Biomedical Inc 公司
Lifecore Biomedical, Inc. 是一家完全一體化的合同開發和製造組織 (CDMO)。該公司爲生物材料市場設計、開發、製造和銷售差異化產品，並向合作伙伴授權技術應用。該公司在注射器和小瓶中無菌注射級藥品的開發、灌裝和完成方面提供高度差異化的能力。該公司參與制造散裝藥用級透明質酸鈉 (HA)，以及用於治療一系列醫療狀況和程序的注射產品的配製和灌裝注射器和小瓶。該公司利用其發酵工藝和無菌配方和灌裝專業知識來開發用於多種應用的基於 HA 的產品，並利用非 HA 設備和藥物機會。
Lifecore Biomedical Inc簡介
公司代碼LFCR
公司名稱Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOMr. Paul Josephs
員工數量406
證券類型Ordinary Share
年結日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編55318
電話19523684300
網址https://www.lifecore.com/
公司代碼LFCR
上市日期Feb 15, 1996
CEOMr. Paul Josephs
Lifecore Biomedical Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
Investor Relations
Investor Relations
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
收入明細
單位: USD更新時間: 3月4日 週二
單位: USD更新時間: 3月4日 週二
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地區USD
名稱
營收
佔比
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
其他
1.50M
5.43%
業務
地區
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
股東統計
更新時間: 9月20日 週六
更新時間: 9月20日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.91%
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.91%
股東類型
持股股東
佔比
Hedge Fund
30.47%
Investment Advisor
24.54%
Investment Advisor/Hedge Fund
18.34%
Individual Investor
1.85%
Research Firm
1.81%
Bank and Trust
0.12%
Private Equity
0.08%
Venture Capital
0.05%
Insurance Company
0.02%
其他
22.71%
機構持股
更新時間: 10月5日 週日
更新時間: 10月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
203
28.26M
75.43%
-694.17K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wynnefield Capital, Inc.
4.70M
9.16%
--
--
Jun 30, 2025
Legion Partners Asset Management, LLC
4.43M
8.63%
--
--
Jun 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
7.19%
+78.69K
+2.18%
Jun 30, 2025
325 Capital LLC
2.16M
4.21%
+1.00
+0.00%
Sep 02, 2025
Laughing Water Capital, LP
1.90M
3.7%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
3.51%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.72M
3.35%
+90.16K
+5.52%
Jun 30, 2025
The Vanguard Group, Inc.
1.61M
3.13%
+63.30K
+4.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
775.49K
1.51%
+25.00K
+3.33%
Jun 30, 2025
GrizzlyRock Capital, LLC
734.53K
1.43%
+734.53K
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.04%
WisdomTree US SmallCap Fund
佔比0.03%
Global X Russell 2000 ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Motley Fool Next Index ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
